Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Kidney International

• Publication date

  2010-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/ki.2010.41PMID 20375980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ROS‐mediated p38α MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas‐mediated cell death in Taiwan cobra phospholipase A2‐treated U937 cells

  2009cited by this paper
• Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.

  2008cited by this paper
• Membranous nephropathy

  2008cited by this paper
• Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury.

  2008cited by this paper
• Role of Rho-GTPases in complement-mediated glomerular epithelial cell injury.

  2007cited by this paper
• Terminal complement complex C5b‐9‐treated human monocyte‐derived dendritic cells undergo maturation and induce Th1 polarization

  2007cited by this paper
• Membranous nephropathy.

  2007cited by this paper
• Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

  2006cited by this paper
• Cellular and molecular biology of membranous nephropathy.

  2006cited by this paper
• Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling

  2006cited by this paper
• Different Effect of Cyclosporine A and Mycophenolate Mofetil on Passive Heymann Nephritis in the Rat

  2005cited by this paper
• Cellular response to injury in membranous nephropathy.

  2005cited by this paper
• Regulation and termination of NADPH oxidase activity

  2005cited by this paper
• Experimental membranous nephropathy redux.

  2005cited by this paper
• Activation and assembly of the NADPH oxidase: a structural perspective.

  2005cited by this paper
• Management of membranous nephropathy: when and what for treatment.

  2005cited by this paper
• Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization.

  2005cited by this paper
• Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.

  2005cited by this paper
• Podocyte biology in human disease

  2005cited by this paper
• Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation.

  2004cited by this paper
• Estimation of podocyte number: a comparison of methods.

  2004cited by this paper
• Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies.

  2004cited by this paper
• A podocentric view of nephrology

  2004cited by this paper
• Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy.

  2003cited by this paper
• Immunosuppressive and Anti-Inflammatory Mechanisms of Triptolide, the Principal Active Diterpenoid from the Chinese Medicinal Herb Tripterygium wilfordii Hook. f.

  2003cited by this paper
• Restraint of Proinflammatory Cytokine Biosynthesis by Mitogen-Activated Protein Kinase Phosphatase-1 in Lipopolysaccharide-Stimulated Macrophages

  2002cited by this paper
• CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b‐8 as well as C5b‐9

  2002cited by this paper
• Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.

  2002cited by this paper
• Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy.

  2002cited by this paper
• Idiopathic membranous glomerulonephritis.

  2001cited by this paper
• Enhanced ROS Production in Oncogenically Transformed Cells Potentiates c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Activation and Sensitization to Genotoxic Stress

  2001cited by this paper
• Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

  2000cited by this paper
• Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation*

  1999cited by this paper
• Triptolide induces apoptotic death of T lymphocyte.

  1998cited by this paper
• Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro.

  1997cited by this paper
• Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

  1997cited by this paper
• Role of C5b-9 in experimental membranous nephropathy.

  1992cited by this paper
• Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats.

  1988cited by this paper
• Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation.

  1987cited by this paper
• Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells.

  1986cited by this paper
• Interactions of dimethyl sulfoxide and nonsteroidal anti-inflammatory agents in passive Heymann's nephritis.

  1986cited by this paper
• Complement and the direct mediation of immune glomerular injury: a new perspective.

  1985cited by this paper
• Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.

  1984cited by this paper
• Passive Heymann's nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins.

  1980cited by this paper
• Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.

  1980cited by this paper
• Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii.

  1972cited by this paper

• Minnelide ameliorates Col4a5+/- mice by upregulating Col4a5 and alleviating endoplasmic reticulum stress.

  2026cites this paper
• Triptolide in renal disorders: dual roles of therapeutic potential and nephrotoxicity: a narrative review

  2026cites this paper
• Network Pharmacology Integration and Experimental Verification to Elucidate the Molecular Mechanisms of Triptolide in Treating Membranous Nephropathy

  2025cites this paper
• Traditional Chinese medicine formulas and phytochemicals: novel opportunities for membranous nephropathy treatments

  2025cites this paper
• Jianpi Qushi Heluo formula ameliorates podocytes injury related with ROS-mediated NLRP3 inflammasome activation in membranous nephropathy by promoting PINK1-dependent mitophagy

  2025cites this paper
• Triptolide Attenuates Renal Slit Diagram to Tight Junction Transition in Diabetic Kidney Disease by Regulating Nrf2-Ferroptosis Pathway.

  2024cites this paper
• Glomerulus-Targeted ROS-Responsive Polymeric Nanoparticles for Effective Membranous Nephropathy Therapy.

  2024cites this paper
• Early Diagnosis and Treatment of Kidney Injury: A Focus on Urine Protein

  2024cites this paper
• Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives

  2024cites this paper
• The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study

  2024cites this paper
• Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway

  2024cites this paper
• Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy

  2024cites this paper
• Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways.

  2023cites this paper
• Biofactors regulating mitochondrial function and dynamics in podocytes and podocytopathies

  2023cites this paper
• Use of Chinese Herbal Medicine to Inhibit Podocyte Damage as Therapeutic Strategy for Membranous Nephropathy

  2023cites this paper
• Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis

  2023cites this paper
• Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria

  2023cites this paper
• Kunxian capsule alleviates podocyte injury and proteinuria by inactivating β-catenin in db/db mice

  2023cites this paper
• Stigma maydis polysaccharides protect podocyte injury by reducing oxidative stress and apoptosis

  2023cites this paper
• Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury

  2023cites this paper
• Friend or foe? The dual role of triptolide in the liver, kidney, and heart.

  2023cites this paper
• A worldwide bibliometric analysis of triptolide research from 1997 to 2021.

  2022cites this paper
• Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking

  2022cites this paper
• A systematic review of potential candidates of herbal medicine in treatment of chronic kidney disease

  2022cites this paper
• Mechanism for the therapeutic effect of Tripterygium wilfordii Hook. f. preparations on IgA nephropathy.

  2022cites this paper
• Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

  2022cites this paper
• Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy

  2022cites this paper
• Mitochondrial Oxidative Stress and Cell Death in Podocytopathies

  2022cites this paper
• Mechanism of action of Tripterygium wilfordii for treatment of idiopathic membranous nephropathy based on network pharmacology

  2022cites this paper
• Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway

  2022cites this paper
• Triptolide Attenuates Muscular Inflammation and Oxidative Stress in a Delayed-Onset Muscle Soreness Animal Model

  2022cites this paper
• Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy

  2022influential citation
• The critical role of the Hippo signaling pathway in kidney diseases

  2022cites this paper
• In Silico Analysis of Antioxidant Phytochemicals with Potential NADPH Oxidase Inhibitory Effect

  2022cites this paper
• TET2 mediated demethylation is involved in the protective effect of triptolide on podocytes.

  2021cites this paper
• Parenteral Nutrition and Cardiotoxicity

  2021cites this paper
• Structural modulation of gut microbiota during alleviation of experimental passive Heymann nephritis in rats by a traditional Chinese herbal formula.

  2021cites this paper
• Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway

  2021cites this paper
• Integrin β3 Induction Promotes Tubular Cell Senescence and Kidney Fibrosis

  2021cites this paper
• Mechanism of Tripterygium Wilfordii for the Treatment of Idiopathic Membranous Nephropathy Based on Network Pharmacology

  2021cites this paper
• Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease

  2021cites this paper
• Jianpi Qushi Heluo Formula alleviates renal damages in Passive Hemann nephritis in rats by upregulating Parkin-mediated mitochondrial autophagy

  2021cites this paper
• Biomarker Identification in Membranous Nephropathy Using a Long Non-coding RNA-Mediated Competitive Endogenous RNA Network

  2021cites this paper
• Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.

  2021cites this paper
• Natural product therapies in chronic kidney diseases: An update.

  2021cites this paper
• Tripterygium glycoside suppresses epithelial-to-mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway

  2021cites this paper
• Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy

  2021cites this paper
• Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria

  2021cites this paper
• Efficacy and Safety of Tripterygium Glycoside in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis Based on the Duration of Medication

  2021cites this paper
• Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway

  2020cites this paper
• Long non-coding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating NLRP3.

  2020cites this paper
• Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis

  2020cites this paper
• Clinical Study Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial

  2020cites this paper
• Triptolide potentiates the cytoskeleton-stabilizing activity of cyclosporine A in glomerular podocytes via a GSK3β dependent mechanism.

  2020cites this paper
• Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial

  2020cites this paper
• Differential toxicities of triptolide to immortalized podocytes and the podocytes in vivo.

  2019cites this paper
• Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases—A Review

  2019influential citation
• Cell Biology International

  2019cites this paper
• Triptolide preserves glomerular barrier function via the inhibition of p53-mediated increase of GADD45B.

  2019cites this paper
• Biomarker prediction for membranous nephropathy prognosis by microarray analysis

  2019cites this paper
• Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis

  2019cites this paper
• Tripterygium and its extracts for diabetic nephropathy: Efficacy and pharmacological mechanisms.

  2019cites this paper
• Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy

  2018cites this paper
• Traditional Chinese Medicine for Refractory Nephrotic Syndrome: Strategies and Promising Treatments

  2018cites this paper
• Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.

  2018cites this paper
• Cellular death, reactive oxygen species (ROS) and diabetic complications

  2018cites this paper
• Tripterygium glycoside protects against puromycin amino nucleoside-induced podocyte injury by upregulating autophagy

  2018cites this paper
• Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA‐137/Notch1 pathway

  2018cites this paper
• Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B

  2018cites this paper
• Tripterygium glycosides for treatment of nephrotic syndrome: A systematic review and meta-analysis of randomised controlled trials

  2018cites this paper
• (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.

  2017cites this paper
• Betulinic acid, isolated from the leaves of Syzygium cumini (L.) Skeels, ameliorates the proteinuria in experimental membranous nephropathy through regulating Nrf2/NF-κB pathways.

  2017cites this paper
• Chinese medicine for diabetic kidney disease in China

  2017cites this paper
• Triptolide protects podocytes from TGF-β-induced injury by preventing miR-30 downregulation.

  2017cites this paper
• Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway

  2017cites this paper
• Tripterygium wilfordii Hook F is efficacious in the treatment of Henoch-Schönlein purpura nephritis in children

  2016cites this paper
• Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models

  2016cites this paper
• The evolution of morphological variants of focal segmental glomerulosclerosis: a repeat biopsy-based observation.

  2016cites this paper
• Efficacy of triptolide on the apoptosis of tonsillar mononuclear cells from patients with IgA nephropathy

  2016cites this paper
• GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway

  2016cites this paper
• Triptolide reduces podocytes injury through blocking ERK and JNK pathways in passive Heymann nephritis ( PHN ) model

  2016influential citation
• Nox and renal disease.

  2015cites this paper
• Podocyte dysfunction in atypical haemolytic uraemic syndrome

  2015cites this paper
• Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy

  2015cites this paper
• Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin.

  2015cites this paper
• Acetaminophen attenuates glomerulosclerosis in obese Zucker rats via reactive oxygen species/p38MAPK signaling pathways.

  2015cites this paper
• Anti-inflammatory effects of triptolide on IgA nephropathy in rats

  2015cites this paper
• Recent Advances in Traditional Chinese Medicine for Kidney Disease.

  2015cites this paper
• Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children

  2015cites this paper
• Triptolide Protects Podocytes from Injury

  2014cites this paper
• Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation

  2014cites this paper
• Research Progress on Intervention of Triptolide in Kidney Diseases

  2014cites this paper
• The Calcineurin Inhibitor Tacrolimus Reduces Proteinuria in Membranous Nephropathy Accompanied by a Decrease in Angiopoietin-Like-4

  2014cites this paper
• The Water-Soluble Triptolide Derivative PG490-88 Protects against Cisplatin-Induced Acute Kidney Injury

  2014cites this paper
• Effect and safety of Tripterygium Hypoglaucum (Lévl.) hutch in treating proteinuria of kidney transplant recipients

  2014cites this paper
• The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults.

  2013cites this paper
• Simvastatin increases ADAMTS13 expression in podocytes.

  2013cites this paper
• Role of Rho-GTPases and their regulatory proteins in glomerular podocyte function.

  2013influential citation
• Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial

  2013cites this paper
• Complement-mediated cellular injury.

  2013cites this paper